These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17726225)

  • 1. Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry.
    Hill JM; Hauser JM; Sheppard LM; Abebe D; Spivak-Pohis I; Kushnir M; Deitch I; Gozes I
    J Mol Neurosci; 2007; 31(3):183-200. PubMed ID: 17726225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide antagonist treatment during mouse embryogenesis impairs social behavior and cognitive function of adult male offspring.
    Hill JM; Cuasay K; Abebe DT
    Exp Neurol; 2007 Jul; 206(1):101-13. PubMed ID: 17521630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation.
    Sahir N; Brenneman DE; Hill JM
    J Mol Neurosci; 2006; 30(3):329-40. PubMed ID: 17401158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.
    Giladi E; Hill JM; Dresner E; Stack CM; Gozes I
    J Mol Neurosci; 2007; 33(3):278-83. PubMed ID: 17952637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior.
    Lim MA; Stack CM; Cuasay K; Stone MM; McFarlane HG; Waschek JA; Hill JM
    Int J Dev Neurosci; 2008 Aug; 26(5):423-34. PubMed ID: 18423945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period.
    Wu JY; Henins KA; Gressens P; Gozes I; Fridkin M; Brenneman DE; Hill JM
    Peptides; 1997; 18(8):1131-7. PubMed ID: 9396053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPAC receptor signaling modulates grouping behavior and social responses to contextual novelty in a gregarious finch: a role for a putative prefrontal cortex homologue.
    Kingsbury MA; Miller KM; Goodson JL
    Horm Behav; 2013 Aug; 64(3):511-8. PubMed ID: 23899763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.
    Gressens P; Hill JM; Paindaveine B; Gozes I; Fridkin M; Brenneman DE
    J Clin Invest; 1994 Nov; 94(5):2020-7. PubMed ID: 7962548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice.
    Stack CM; Lim MA; Cuasay K; Stone MM; Seibert KM; Spivak-Pohis I; Crawley JN; Waschek JA; Hill JM
    Exp Neurol; 2008 May; 211(1):67-84. PubMed ID: 18316078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal polypeptide regulates dynamic changes in astrocyte morphometry: impact on gonadotropin-releasing hormone neurons.
    Gerhold LM; Wise PM
    Endocrinology; 2006 May; 147(5):2197-202. PubMed ID: 16469806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
    Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M; Gozes I
    Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.
    Gozes I; Perl O; Giladi E; Davidson A; Ashur-Fabian O; Rubinraut S; Fridkin M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4143-8. PubMed ID: 10097177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis.
    Zupan V; Hill JM; Brenneman DE; Gozes I; Fridkin M; Robberecht P; Evrard P; Gressens P
    J Neurochem; 1998 May; 70(5):2165-73. PubMed ID: 9572304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome.
    Hill JM; Ades AM; McCune SK; Sahir N; Moody EM; Abebe DT; Crnic LS; Brenneman DE
    Exp Neurol; 2003 Sep; 183(1):56-65. PubMed ID: 12957488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A VIP hybrid antagonist: from developmental neurobiology to clinical applications.
    Gozes I; Fridkin M; Brenneman DE
    Cell Mol Neurobiol; 1995 Dec; 15(6):675-87. PubMed ID: 8719036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice.
    Brown TM; Colwell CS; Waschek JA; Piggins HD
    J Neurophysiol; 2007 Mar; 97(3):2553-8. PubMed ID: 17151217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
    Gozes I; McCune SK; Jacobson L; Warren D; Moody TW; Fridkin M; Brenneman DE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):959-66. PubMed ID: 1646331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light and electron microscopic immunocytochemical analysis of the neurovascular relationships of choline acetyltransferase and vasoactive intestinal polypeptide nerve terminals in the rat cerebral cortex.
    Chédotal A; Umbriaco D; Descarries L; Hartman BK; Hamel E
    J Comp Neurol; 1994 May; 343(1):57-71. PubMed ID: 8027437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.